VesiCURE Therapeutics
PrivateLast Round
Angel
Sep 17, 2021
Company Overview
VesiCURE Therapeutics operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was an Angel round in September 2021.
VesiCURE Therapeutics is a biotechnology company that researches and develops exosome innovative drugs and drug delivery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VesiCURE Therapeutics Comparables
Compare VesiCURE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TheraXyte BioScience | 87% | |
| Carmine Therapeutics | 83% | |
| Shanghai Stexo Biotechnology Co., Ltd. | 79% |
For institutional investors. Book with your work email.
VesiCURE Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VesiCURE Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Angel |
| Legend Star | Angel |
| YuanBio Venture Capital | Angel |
| Northern Light Venture Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 394% MoM, reaching 1.8K.
- Jan 22, 2026
Monthly visitors increased 34% MoM.
For institutional investors. Book with your work email.
VesiCURE Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VesiCURE Therapeutics's valuation, stock price, and market status.
Is VesiCURE Therapeutics a public or private company?
VesiCURE Therapeutics is a private company.
What is the current stock price of VesiCURE Therapeutics?
VesiCURE Therapeutics is a private company, so its shares have no public market price. Caplight tracks VesiCURE Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VesiCURE Therapeutics worth (valuation)?
Valuation information for VesiCURE Therapeutics is not publicly available.
Can I buy VesiCURE Therapeutics stock?
VesiCURE Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VesiCURE Therapeutics's last funding round?
VesiCURE Therapeutics's most recent funding round was Angel on September 17, 2021.
Who are the main investors in VesiCURE Therapeutics?
Key investors in VesiCURE Therapeutics include YuanBio Venture Capital.
Will VesiCURE Therapeutics IPO soon?
No public IPO plans have been announced for VesiCURE Therapeutics.
How can I track VesiCURE Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in VesiCURE Therapeutics's shares on secondary markets.